Eurasian heart journal · 2021 · 14 citations · 193 references
MedicineCardiologyInternal MedicineClinical CardiologyClinical Decision SupportPreventive CardiologyAcute Coronary Syndrome CareAcute Coronary Syndrome InterventionAcute Coronary SyndromesClinical Practice GuidelinesGuideline ImplementationStandard Of CareAcute Coronary Syndrome DetectionAcute Coronary Syndrome EvaluationAcute Coronary Syndrome ManagementAcute Coronary Syndrome Risk StratificationClinical Judgment DevelopmentClinical Judgment In PrognosticationHigh-risk Non-st Elevation Myocardial InfarctionNon-st-elevation Myocardial Infarction
The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
193
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres et al. · European Heart Journal · 2020 · 9.9K citations · Full text